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Abstract
A form of hereditary cerebellar ataxia has recently been described in the Norwegian Buhund
dog breed. This study aimed to identify the genetic cause of the disease. Whole-genome
sequencing of two Norwegian Buhund siblings diagnosed with progressive cerebellar ataxia
was carried out, and sequences compared with 405 whole genome sequences of dogs of
other breeds to filter benign common variants. Nine variants predicted to be deleterious seg-
regated among the genomes in concordance with an autosomal recessive mode of inheri-
tance, only one of which segregated within the breed when genotyped in additional
Norwegian Buhunds. In total this variant was assessed in 802 whole genome sequences,
and genotyped in an additional 505 unaffected dogs (including 146 Buhunds), and only four
affected Norwegian Buhunds were homozygous for the variant. The variant identified, a T to
C single nucleotide polymorphism (SNP) (NC_006585.3:g.88890674T>C), is predicted to
cause a tryptophan to arginine substitution in a highly conserved region of the potassium
voltage-gated channel interacting protein KCNIP4. This gene has not been implicated previ-
ously in hereditary ataxia in any species. Evaluation of KCNIP4 protein expression through
western blot and immunohistochemical analysis using cerebellum tissue of affected and
control dogs demonstrated that the mutation causes a dramatic reduction of KCNIP4 protein
expression. The expression of alternative KCNIP4 transcripts within the canine cerebellum,
and regional differences in KCNIP4 protein expression, were characterised through RT-
PCR and immunohistochemistry respectively. The voltage-gated potassium channel protein
KCND3 has previously been implicated in spinocerebellar ataxia, and our findings suggest
that the Kv4 channel complex KCNIP accessory subunits also have an essential role in
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voltage-gated potassium channel function in the cerebellum and should be investigated as
potential candidate genes for cerebellar ataxia in future studies in other species.
Author summary
Hereditary ataxias, which are a group of disorders characterised by incoordination of
movement, are typically incurable and there are often no disease-modifying treatments
available. Canine hereditary ataxias are a notable group of movement disorders in dogs,
and represent well characterised naturally occurring disease models of ataxia that can help
improve our understanding of the underlying biology of the disorder in both dogs and
humans. We used the whole genome sequences of two affected siblings to investigate the
genetic cause of a slowly progressive form of hereditary ataxia in the Norwegian Buhund
dog breed, and identified a single base change within the KCNIP4 gene. We have charac-
terised the expression of KCNIP4 in the dog, and investigated the effect of the identified
mutation. This gene has not previously been implicated in inherited ataxia in any species,
and our findings suggest that this and related genes represent potential candidates for
ataxia in future studies in other species. Our findings will allow dog breeders to avoid pro-
ducing affected dogs, reduce the disease allele frequency, and eventually eliminate the dis-
ease from the breed, through the use of a DNA test.
Introduction
Hereditary ataxias are a group of movement disorders, typified by incoordination of gait,
limbs, or eyes, primarily caused by inherited dysfunction of the cerebellum and/or its afferent
or efferent pathways [1]. In humans autosomal recessive and dominant forms of hereditary
ataxia have been reported, in addition to mitochondrial, and, in the case of fragile X tremor-
ataxia, X-linked forms. Inherited ataxias are typically not curable and there are often not any
disease-modifying treatments available [1, 2].
Multiple examples of hereditary ataxia have been described in purebred dogs [3–9].
Although the specific diseases are often rare, and the genetic mutations can be breed-specific,
hereditary ataxia is a key cause of movement disorders in dogs. Canine hereditary ataxia is typ-
ically inherited in an autosomal recessive manner, and disease-causing variants have been
identified for some breeds [3–12]. Some of the genes implicated in canine ataxia had not previ-
ously been associated with disease in humans [12–15], whereas other forms of canine ataxia
are caused by variants within the same genes that are associated with well characterised forms
of human ataxia [4–6, 16]. Canine hereditary ataxia is a naturally occurring disease model and
research into the genetics of ataxia in purebred dogs can help improve the understanding of
the underlying molecular mechanisms of human disease.
Hereditary ataxias in humans are classified by mode of inheritance, whereas in dogs, where
the underlying genetic basis is often less well defined, have recently been classified based on
the clinical signs and the neuronal structures affected [1, 3]. The five classes of canine heredi-
tary ataxia are cerebellar cortical degeneration (CCD), spinocerebellar degeneration, canine
multiple system degeneration (CMSD), cerebellar ataxias without significant neurodegenera-
tion, and episodic ataxias [3].
Different genetic approaches have successfully been used to identify the causal mutations
for canine hereditary ataxia. Homozygosity mapping, linkage analysis, and targeted
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resequencing was used to investigate spinocerebellar ataxia in the Italian Spinone, and identi-
fied a GAA repeat expansion in ITPR1, a calcium channel that regulates intracellular calcium
levels [4]. mRNA sequencing and a candidate gene approach was used to identify an 8bp dele-
tion in SPTBN2 (β-III spectrin, involved in the development of Purkinje cells) causing CCD in
Beagles [16]. Genome-wide association studies (GWAS) have been used to identify the causal
mutations for CCD in Finnish Hounds (SEL1L, targeted degradation of misfolded or unassem-
bled peptides), and Old English Sheepdogs and Gordon Setters (RAB24, which has a role in
autophagy); and spinocerebellar ataxia in Russell Terrier Group dogs (CAPN1, which
encodes μ-calpain, a subunit of calcium dependent cysteine protease) [13–15]. Whole genome
sequencing of single cases of ataxia has been used more recently to successfully identify causal
variants for CCD in the Hungarian Vizsla (SNX14, which has a role in the maintenance of neu-
ronal excitability and synaptic transmission, and is associated with cerebellar ataxia in
humans) [5] and spinocerebellar ataxia in Russell Group Terriers (KCNJ10, a potassium chan-
nel gene) [17]. Both of these studies used control genomes, and predicted effect on the protein
sequence, to filter common benign variants, and then identified variants within candidate
genes for genotyping in additional dogs.
The clinical and histopathological characteristics of hereditary cerebellar ataxia in the Nor-
wegian Buhund have been described previously in a study of four cases presenting with mild
and slowly progressive cerebellar ataxia, characterised by a broad base stance and hypermetria
in all four limbs, truncal ataxia, and fine head tremors [18]. At referral two dogs (siblings)
were aged 12 weeks, and two other affected dogs were aged 16 and 20 weeks. Histopathological
analysis of the cerebellum showed minor signs of degeneration and reduced expression of Pur-
kinje cell differentiation markers calbindin-D-28K and ITPR1 in some cerebellar regions [18].
Pedigree analysis suggested an autosomal recessive mode of inheritance. Genome-wide
mRNA-sequencing of two affected siblings and subsequent investigation of 20 candidate genes
in this dataset did not identify any potentially causal variants for the disease [18].
The present study aimed to identify the underlying genetic cause of ataxia in the Norwegian
Buhund breed using whole genome sequencing of the two affected siblings. A mutation within
KCNIP4, a novel gene for cerebellar ataxia, was identified.
Results
Whole genome variant filtering
Whole genome sequences of two ataxia-affected Norwegian Buhund siblings were initially
compared with the Boxer reference sequence CanFam3.1 and whole genome sequences of 44
dogs of 29 different breeds (control genomes). Variants identified were filtered to leave only
those which were homozygous in both of the affected dogs, but which were homozygous for
the reference or an alternative allele in the control dogs. Our hypothesis was that the causal
variant is rare and private to the Norwegian Buhund breed. From this, a total of 26,073 segre-
gating variants were identified. Additional filtering by variant effect, leaving only high-effect
variants that were predicted to directly affect a protein coding sequence, or disrupt a transcript,
reduced the number to 121.
The 121 variants were then further filtered using whole genome sequence variant data from
the Dog Biomedical Variant Database Consortium (DBVDC) [19]. The consortium dataset
included 361 additional whole genome sequences comprising 96 different pure breeds, three
wolves, and seven types of mixed-breed dog. The variants were filtered to leave only those
absent in all of the consortium genomes. This left 16 high-effect variants that were homozy-
gous in the two affected dogs and were not present in any of the other whole genome
sequences. Seven of the 16 variants were predicted to be tolerated and benign by two variant
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effect prediction tools; SIFT and PolyPhen-2. The nine remaining variants were taken forward
for genotyping in additional Norwegian Buhunds.
Variant segregation in additional dogs
Each of the nine variants was initially genotyped in 14 additional, unaffected, Buhunds. These
included two full siblings of the affected dogs and two obligate carriers which were identified
through the pedigree (S1 Fig). Only one of the nine variants segregated as would be expected
for an autosomal recessive mode of inheritance: a nonsynonymous SNP in the KCNIP4 gene
(NC_006585.3:g.88890674T>C) (S1 Table). This variant was genotyped in a further 56
Buhunds (archived DNA samples collected between 2008 and 2011) not reported to have
ataxia (a total of 70 tested “UK Buhund set 1”). Of these 70 dogs 24 were heterozygous for the
KCNIP4 variant (T/C), and the other 46 were homozygous for the CanFam3.1 reference allele
(T/T) (Table 1). None of the unaffected dogs were homozygous for the KCNIP4 variant. Geno-
typing unaffected Norwegian Buhunds sampled in 2017 revealed that this contemporary set of
36 UK dogs (“UK Buhund Set 2”) included three heterozygotes, and within 40 dogs sampled
in Finland (“Finnish Buhund Set”) one heterozygote was identified (Table 1). Neither of these
sample sets included any dogs homozygous for the variant. Two additional Norwegian
Buhunds were previously diagnosed with cerebellar ataxia in 1998 and 2002. Genotyping these
additional cases, in addition to the two siblings used for whole genome sequencing, confirmed
that all four affected dogs were homozygous for the KCNIP4 variant (Table 1).
For further validation and to investigate if the variant is confined to the Norwegian Buhund
breed a panel of 359 dogs of 122 other breeds was genotyped. The KCNIP4 variant was not
present in this multi-breed panel (Table 1) (S2 Table).
Variant data for additional whole genome sequences subsequently became available after
the initial analysis. These additional genomes included 140 in-house genomes and 255
genomes in the DBVDC consortium [19], all of which were homozygous for the reference
allele.
In total the KCNIP4 variant was assessed in 802 whole genome sequences, including dogs
of 158 breeds, 13 mixed breed dogs, and 8 wolves (S3 Table), and genotyped in an additional
505 unaffected dogs (including 146 Norwegian Buhunds), and only the four affected Buhunds
(two whole genome sequences and two genotyped) were homozygous for the variant. These
results demonstrate that the variant segregates with disease and is confined to the Norwegian
Buhund breed.
Bioinformatics tools predict the KCNIP4 variant to be deleterious
The KCNIP4 variant is a nonsynonymous T/C SNP causing a tryptophan to arginine amino
acid change. The nucleotide, and codon within which the KCNIP4 variant is located, is con-
served across 99 species of mammal (UCSC) (S4 Table). Tryptophan is highly conserved at
Table 1. Genotypes of Norwegian Buhunds and a multi-breed panel for the KCNIP4 variant.
T/T T/C C/C Total
Buhund Cases 0 0 4 4
UK Buhund Set 1 46 24 0 70
UK Buhund Set 2 33 3 0 36
Finnish Buhund Set 39 1 0 40
Multi-breed Panel 359 0 0 359
Total 477 28 4 509
https://doi.org/10.1371/journal.pgen.1008527.t001
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this location, and so is the flanking amino acid sequence in 19 species of mammal (16 pri-
mates) (UCSC) (S2 Fig). SIFT predicted the variant to be “deleterious” (SIFT value: 0), and
Polyphen-2 “probably damaging” (Polyphen-2 value: 0.99) [20, 21]. The effect of the variant
was also assessed using a third tool, Mutation Taster, which predicted the variant to be “disease
causing” (probability: 0.99) [22].
At least five KCNIP4 transcripts with alternative first exons are expressed
in canine cerebellar tissue
There are four NCBI RefSeq KCNIP4 transcripts, and seven Ensembl KCNIP4 transcripts,
annotated for the canine genome (S5 Table). Two of the canine Ensembl transcripts
(ENSCAFT00000060142.1, ENSCAFT00000083618.1) match canine RefSeq transcripts
(XM_014112663.2, XM_003434400.4), making a total of nine unique KCNIP4 transcripts
annotated for the canine genome. Three of the NCBI RefSeq canine KCNIP4 transcripts corre-
spond to human Ensembl transcripts and transcripts reported previously to be expressed in
human and mouse cerebellum [23] (S5 Table). The corresponding protein RefSeq for canine
transcripts XM_014112663.2, XM_003434400.4, and XM_005618660.3 align to the protein
sequences for human transcripts KCNIP4-1bΔ2 (ENST00000382148.7), KCNIP4-1dΔ2
(ENST00000382150.8), and KCNIP4-1eΔ2 (ENST00000382149.9) respectively (S5 Table) (Fig
1A). These three transcripts were confirmed using RNA sequencing data for canine cerebellum
from dogs of multiple breeds, including the two affected Norwegian Buhund siblings.
Two other transcripts (KCNIP4-1a and KCNIP4-1aΔ2) which have been reported to be
expressed in human and mouse cerebellum do not have corresponding canine RefSeq tran-
scripts [23] (S5 Table). An assessment of the syntenic region for the first exon for these tran-
scripts in CanFam3.1 revealed that there is a gap in the canine genome at this location
(CanFam3.1 Chr3:87,771,558–87,771,880) (Fig 1A). When translated into the amino acid
sequence, unmapped reads from the RNA sequencing data which were paired to the mapped
reads of the flanking exons (exon 2 and exon 3), aligned with the N-terminal protein sequence
corresponding to the first exon of human transcripts KCNIP4-1a (ENST00000382152.7),
which contains “exon 2”, and KCNIP4-1aΔ2 (ENST00000447367.6), in which “exon 3” is the
second exon (Fig 1A) (S5 Table). Reads extending upstream into the gap in the genome from
the gap’s 3’ end (chr3:87,771,880) aligned with part of the missing sequence, confirming that
this gap in the genome is the location of the unaligned exon. A comparison of the identified
transcripts, and the sequence and genomic position of canine Ensembl transcripts ENSCAF
T00000090603.1 and ENSCAFT00000090861.1, revealed that they are partial canine transcript
annotations for KCNIP4-1a and KCNIP4-1aΔ2, but are lacking most of the first exon as a
result of the gap in the genome (S5 Table).
There are also four annotated canine transcripts, one RefSeq and three Ensembl, which do
not match any of the known human KCNIP4 Ensembl transcripts (S5 Table). Two of these
transcripts, ENSCAFT00000079461.1 and ENSCAFT00000061238.1, are indicated in the
annotation to have an additional exon between exons 3 and 4. This additional exon is not seen
in any of the human transcripts or any of the other annotated canine transcripts, and was not
observed in canine cerebellum mRNA sequencing data. Ensembl transcript ENSCAFT000
00026195.4 appears to be an incorrect amalgamation of the first exon of KCNIP4-1eΔ2
(XM_005618660.3), the second exon of KCNIP4-1a, and exons 3 to 9 which are present in all
of the KCNIP4 transcripts (Fig 1A). This transcript was not seen in the mRNA sequencing
data. Canine RefSeq transcript XM_536275.6 is stated to start with the second exon of
KCNIP4-1a, followed by exons 3 to 9. This combination of exons is not seen in any of the
annotated human Ensembl transcripts.
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RT-PCR of RNA extracted from cerebellum tissue samples from two ataxia-affected
Buhunds and five unaffected dogs of other breeds confirmed that at least five transcripts for
KCNIP4, with alternative first exons, are expressed in the canine cerebellum (Fig 1B). The vari-
ant identified in this study is located in exon 6, which Sanger sequencing of the RT-PCR prod-
ucts for the Buhund siblings and a Golden Retriever confirmed is expressed in all five of these
transcripts (Fig 1C). All of the confirmed transcripts contain exons 3 to 9.
RT-qPCR of KCNIP4 expression
The relative expression of KCNIP4 in cerebellar tissue samples from the two sibling cases and
five unaffected dogs, in comparison to the ubiquitously expressed TATA box binding protein
(TBP) gene, was assessed using RT-qPCR. The assay for KCNIP4 was designed with primers in
exons 3 and 4, both of which are present in all five of the transcripts shown to be expressed in
the canine cerebellum, allowing the assay to quantify total KCNIP4 transcript expression.
Relative quantification of KCNIP4 was suggestive of reduced expression in cerebellar tissue
from the two affected dogs (ΔΔCq = 0.497) (Fig 2A), although the change in expression was
not statistically significant (Student’s T-test, p = 0.07).
Fig 1. (A) An illustration of the exon composition of the five canine KCNIP4 transcripts identified using mRNA and
whole genome sequencing data and alignment with known human transcripts. KCNIP4-1a and KCNIP4-1aΔ2 share exon
1a as their first exon, whereas all other transcripts have unique first exons. In these five canine transcripts, exon 2 is only
present in KCNIP4-1a. Exons 3 to 9 are shared across all five transcripts. Coordinates for the first and second exons of
each transcript are in S5 Table. The genomic region containing exons 3 to 9 as labelled in the Figure is Chr3: 88,780,584–
88,894,638. The genomic region containing all of the transcripts is Chr3: 87,771,818–88,894,638. (B) RT-PCR of five
KCNIP4 transcripts in canine cerebellum samples for seven dogs. From left to right: no template water control (NTC);
two ataxia-affected Norwegian Buhunds (NB); Labrador Retriever cross breed (LR-X); Golden Retriever (GR); Siberian
Husky cross breed (XB); Beagle (BE); Great Dane (GD). (C) Sanger sequencing chromatogram demonstrating that exon
“6”, containing the mutation, is present in the transcripts expressed in the canine cerebellum. The sequences shown are
for KCNIP4-1bΔ2. NB: Norwegian Buhund, GR: Golden Retriever.
https://doi.org/10.1371/journal.pgen.1008527.g001
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Western blot shows loss of KCNIP4 in cerebellum of cases
Western blot analysis was carried out for KCNIP4 using cerebellum tissue lysate from two
cases and six control dogs. Three of the controls were affected by cerebellar ataxia but were of
other breeds for which the causal mutation is known, and the remaining three were unaffected
by ataxia. The western blot showed a clear change in KCNIP4 expression in the cerebellum tis-
sue from the Buhund case (Fig 2B). Three bands are visible for the control tissues, at approxi-
mately 28 kDa, 26 kDa, and 22 kDa. The band with the highest saturation in all controls is at
28 kDa, with the lower molecular weight bands observed to be fainter in the three controls
which were affected by genetically distinct forms of cerebellar ataxia. The two lower bands are
absent, or too faint to observe, in the two Buhund cases. The 28 kDa band appears to still be
present in the Buhund cases, but at a much lower saturation. A fourth band is observable for
all eight tissue lysates at approximately 37 kDa, and has a higher saturation in the two Buhund
cases. The different bands may represent the differently sized isoforms of KCNIP4, although
the band at 37 kDa does not fit within the size ranges of any of the known KCNIP4 isoforms
(S5 Table). The western blot analysis indicates a dramatic reduction of KCNIP4 expression in
dogs homozygous for the KCNIP4 variant, and could suggest a complete loss of some, if not
all, KCNIP4 isoforms.
Immunohistochemistry shows a reduction of KCNIP4 expression in the
cerebellum of an affected Buhund
Expression of KCNIP4 protein was identified immunohistochemically throughout synaptic
glomeruli of the cerebellar granular cell layer and basket cells of the molecular layer in all dogs,
but staining intensity was considerably lower in the Buhund with two copies of the mutation
(Fig 3). As functional differentiation of Purkinje cells appears to underlie regional differences
[18], sagittal and transverse sections of all cerebellar lobuli were examined. Reduction of
KCNIP4 expression was seen throughout the entire cerebellar cortex but more extensive in
Fig 2. (A) Relative quantification (ΔCq) of KCNIP4 in comparison to the ubiquitously expressed control gene TBP in cerebellar tissue
samples of two ataxia affected Buhund siblings (Case) and five ataxia unaffected dogs (Labrador Retriever cross-breed, Siberian Husky cross-
breed, Beagle, Golden Retriever, and a Great Dane) (Control). Black lines show group median. (B) Western blot comparing KCNIP4 protein
expression in the cerebellum tissue lysate of two Norwegian Buhund cases and six control dogs. Top panel: Anti-KCNIP4 western blot.
Bottom panel: Ponceau S total protein loading control. From left to right: two ataxia affected Norwegian Buhunds (NB); Three ataxia-affected
control dogs of other breeds (Parson Russel Terrier (PRT); Beagle (BE); Hungarian Vizsla (V)); three ataxia-unaffected control dogs of other
breeds (Golden Retriever (GR); Siberian Husky cross breed (XB); Labrador retriever cross breed (LR-X)). Approximate sizes of protein
ladder bands are indicated on the left (kDa).
https://doi.org/10.1371/journal.pgen.1008527.g002
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areas where Purkinje cells showed least expression of calbindin and ITPR-1 in the histopatho-
logical analysis carried out previously for the clinical characterisation of the disease [18].
In Silico protein analysis of the 3D structure of KCNIP4 suggests that the
mutation affects protein stability and function
The structure of one KCNIP4 isoform, KChIP4a (KChIP4 was a previous abbreviation for
KCNIP4), has been determined through X-Ray diffraction (PDB ID 3DD4). KChIP4a aligns
perfectly with XP_003434448.1 and KCNIP4-204 (KCNIP4-1dΔ2). This allowed the use of
online tools for predicting the effect of the variant on protein stability. The Eris server, which
uses discrete molecular dynamics, was used to predict the effect of the mutation on the free
energy of the protein’s structure [24]. The tryptophan to arginine substitution caused a pre-
dicted ΔΔG of 7.31 kcal/mol, which indicates a dramatic decrease in stability.
The 3D protein structure was used to investigate the physical location of the amino acid
substitution within the protein. The tryptophan residue affected is within the hydrophobic
core of KCNIP4, and is predicted to interact with the N-terminal helix which sits within the
groove of the protein (Fig 4A). The substitution replaces the non-charged, non-polar,
Fig 3. Immunohistochemical expression patterns of KCNIP4 in the cerebellum of an affected Buhund (A, C) compared to that of two control
dogs (B,D). Top panels: Rostral lobe. Bottom panels: Caudoventral vermis. The Buhund shows a diffusely decreased immunopositivity within
the molecular layer (ML) and granular layer (GL) (brown staining). Thereby, rostral lobe areas (A) present with slightly stronger signal
intensity than the caudoventral vermis (C). This difference matches to regional differences in Purkinje cell marker expression demonstrated
previously [18]. PC: Purkinje cell; FWM: foliary white matter.
https://doi.org/10.1371/journal.pgen.1008527.g003
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hydrophobic tryptophan with the positively charged, polar, arginine. This is likely to have an
impact on the hydrophobicity of the protein’s core. The arginine residue is predicted to inter-
act with different helical structures within the protein compared to tryptophan, no longer
interacting with the N-terminal helix (Fig 4B). The arginine residue is also predicted to over-
lap, and clash, with neighbouring residues (Fig 4C).
Discussion
In the present study we used whole genome sequencing to identify the causal mutation for a
recently characterised cerebellar ataxia in the Norwegian Buhund dog breed [18]. Whole
genome sequencing of single cases of ataxia has recently been used to successfully identify
mutations causing cerebellar cortical degeneration (CCD) in the Hungarian Vizsla and spino-
cerebellar ataxia in Russell Group Terriers [5, 17]. Taken together this suggests that cerebellar
ataxias in the dog are particularly amenable to this approach for the identification of causal
mutations. The approaches used in these two previous studies, however, used the candidacy of
the genes in which variants were found to filter for potentially causal variants [5, 17]. The pres-
ent study used a much larger number of in-house and consortium control sequences to filter
variants to a level manageable for follow-up, allowing the discovery of a likely-pathogenic vari-
ant in KCNIP4, a novel gene for cerebellar ataxia. A previous study that used GWAS and tar-
geted resequencing to investigate a different form of canine cerebellar ataxia in Russell Terrier
Group dogs identified a variant in CAPN1, which had also not previously been implicated in
ataxia in humans [15]. Mutations in this gene were later demonstrated to cause autosomal-
recessive hereditary spastic paraplegia in humans, which is a condition that can present with
cerebellar signs and which is associated with ataxia in some cases [25]. Canine hereditary cere-
bellar ataxia, as a naturally occurring disease model, therefore represents a resource for the
identification of novel genes that should be considered as potential candidates when investigat-
ing similar conditions in humans. The discovery of novel genes for hereditary ataxia (and
other rare, autosomal recessive, or autosomal dominant diseases) in the dog, when only very
Fig 4. 3D models of KCNIP4 with and without the amino acid substitution caused by the mutation identified. (A) KCNIP4 with tryptophan (green) at position
142. (B) KCNIP4 with arginine (orange) at position 142. Blue lines in A) and B) indicate predicted interactions between atoms (including polar and nonpolar
interactions). (C) KCNIP4 with arginine (orange) at position 142, with red lines indicating clashes (interactions where atoms are too close together).
https://doi.org/10.1371/journal.pgen.1008527.g004
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small numbers of cases are available, is therefore becoming increasingly possible with the rapid
expansion of publicly available whole genome sequence datasets [19]. In the future this could
make clinical diagnostic sequencing affordable and efficient for emerging Mendelian canine
conditions.
The mutation identified is a nonsynonymous SNP causing a tryptophan to arginine amino
acid substitution within a highly conserved region of KCNIP4. Voltage-gated potassium chan-
nel-interacting proteins (KCNIP, previously called KChIP) are four calcium binding proteins
which interact with voltage-gated potassium (Kv) channels and modulate A-type potassium
currents [26, 27]. Mutations in KCNIP4 have not been associated with cerebellar ataxia previ-
ously in any species to the authors’ knowledge. However, mutations within KCND3, which
encodes the voltage-gated potassium channel α-subunit Kv4.3, have been found to cause spi-
nocerebellar ataxia type 19/22 in humans [28–32]. Mutations in KCND3 reduce trafficking
and cell surface expression of KV4.3 and suppress the amplitude of the potassium current or
affect channel gating [33]. KChIP4a, an isoform of KCNIP4, has been shown to interact with
Kv4.3 and to modulate its inactivation [34, 35].
RT-qPCR analysis did not demonstrate a statistically significant reduction in the expression
of the KCNIP4 transcript in the affected Buhunds, although it was suggestive of reduced
expression; whereas a dramatic reduction in KCNIP4 protein expression was observed in the
cerebellum of cerebellar ataxia-affected Norwegian Buhunds, through both western blot and
immunohistochemistry. It has been demonstrated previously that changes in the protein
expression of the Kv4 accessory subunits (KCNIP1, KCNIP2, KCNIP3, and KCNIP4) do not
necessarily reflect transcriptional expression [36]. It has been suggested that the formation of
complexes between the accessory subunits and the α-subunits (Kv4.2 or Kv4.3) stabilises the
proteins, leading to increased levels of each protein [36]. The tryptophan to arginine substitu-
tion identified in the current study is predicted to be destabilising and damaging to protein
function. If the predicted effect on protein function prevents the formation of complexes, and
this precludes the stabilisation of the protein, combined with the mutation’s destabilising effect
this could potentially explain the dramatic reduction in protein expression observed without a
significant drop in transcript expression. Only RNA from two cases was available for the RT-
qPCR analysis; inclusion of a larger number of cases would be necessary to confirm this
finding.
Although the western blot and immunohistochemical analysis indicate a considerable
reduction in KCNIP4 protein expression in affected dogs, the exact epitope of the antibody
used is unknown. The immunogen used by the manufacturer consisted of the majority of the
protein’s amino acid sequence, and the epitope has not been mapped. This means that the epi-
tope could be in the region of the mutation, and the mutation could potentially have prevented
antibody binding and thus mimicked an apparent fall in protein expression. However, the
immunohistochemistry demonstrated that there was still some expression in a case, and that
the expression pattern matched that seen previously for KCNIP4 expression in humans and
mice [23], and the variability in expression in the case match that of the Purkinje cell markers
demonstrated in the histopathological analysis carried out previously [18]. This indicates that
the antibody used is still capable of binding the protein containing the variant.
An additional band, at a greater atomic mass than the known KCNIP4 isoforms, was
observed on the western blot. This additional band with a mass of ~37 kDa, which had a higher
intensity in the two cases, could potentially represent an increase in expression of a different
accessory Kv4 subunit, observable as a result of cross-reactivity of the antibody used. Loss of
one of the KCNIPs has previously been observed to result in an increase in protein expression
of the other, non-disrupted KCNIPs [36]. This compensatory mechanism is thought to occur
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through competition between the KCNIPs for binding to α-subunits [36, 37]. The stabilisation
that occurs through binding to the other subunits results in an increase in protein levels.
The three main bands are observed for the control tissues in the western blot, at approxi-
mately 28 kDa, 26 kDa, and 22 kDa, are expected to represent the various isoforms of
KCNIP4, which fit within this approximate size range (S5 Table). The band with the highest
saturation in all controls, at 28 kDa, has a size closest to that expected of KCNIP4-1a. The
lower two bands were observed to be fainter in the three controls which were affected by other
forms of cerebellar ataxia, in comparison to those unaffected by ataxia. We propose that this
difference could be a result of cerebellar degeneration, particularly for the Beagle and Hungar-
ian Vizsla CCD cases, which are forms of ataxia characterised by the loss of Purkinje cells and
depletion of the granular cell layer [5, 16]. The degradation of the cerebellum and cell types
known to express the KCNIP4 protein could feasibly have resulted in the reduction in
KCNIP4 expression observed in comparison to the unaffected controls. In comparison, the
Norwegian Buhund cerebellar ataxia cases, which had two copies of the KCNIP4 variant but
negligible cerebellar degeneration observed in the histopathological analysis [18], demon-
strated almost complete loss of KCNIP4 protein expression in the western blot analysis, and
dramatically reduced expression in the immunohistochemistry, indicating that in these indi-
viduals the loss of protein is caused by the mutation, not the cerebellar degeneration.
Human KCNIP genes have seven 3’ exons (exons 3 to 9, Fig 1A) which are identical in
length and have highly similar sequences between the four genes [23]. The 5’ exons for the
four genes are extremely dissimilar, and each KCNIP gene has multiple 5’ exons which are
unique. The high homology of the genes indicates shared protein function, and the conserva-
tion of the amino acid sequence of exons 3 to 9 suggests that variants in these regions are likely
to be damaging to function. The variant identified in this study is located within exon 6, one of
the highly conserved 3’exons, in a region of the protein which has identical amino acid
sequences in the four canine proteins. The bioinformatics tools we have used show that the
mutation in this conserved region affects the hydrophobic core of the protein, and predict it to
be destabilising and damaging to function.
In addition to demonstrating that a variant within KCNIP4 causes cerebellar ataxia in the
Norwegian Buhund dog breed, we have characterised the gene’s expression in the canine cere-
bellum. RT-PCR analysis and in situ hybridisation studies have demonstrated that KCNIP4 is
expressed in the cerebellum in humans and mice [23]. We have demonstrated that at least five
KCNIP4 transcripts are expressed in canine cerebellum, and that they share high sequence
similarity with the human transcripts, all sharing the seven highly conserved 3’ exons but with
alternative 5’ exons aligning with those seen in humans. A previous in situ hybridisation study
in mice demonstrated that KCNIP4 is expressed in the Purkinje cell layer and granular layer
neurons of the cerebellum [23], and a immunohistochemical study in the rat showed protein
expression throughout the cerebellum but particularly in the granular cell layer [38]. We dem-
onstrate that KCNIP4 protein is also expressed strongly in the granular layer of the canine cer-
ebellum. One transcript was only found in the kidney in humans [23]. Consistent with this,
this transcript, KCNIP4-1cΔ2, was not identified in the canine cerebellum. However, the first
exon of this transcript is a shortened version of the first of the 3’ exons shared by all transcripts,
which makes it impossible to assay using the methods used here; primers designed for this first
exon would amplify all KCNIP4 isoforms. We were unable to locate the 5’ untranslated region
(UTR) for the KCNIP4-1cΔ2 transcript in canine cerebellum mRNA sequencing data.
In the immunohistochemical analysis we observed that expression of KCNIP4 in the canine
cerebellum was predominantly within the granular cell layer, and KCNIP4 expression was
strong throughout the synaptic glomeruli. Previous research has suggested a role for A-type
potassium channels in the regulation of postsynaptic excitability of granule cell dendrites at
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the synapse between granule cells and mossy-fibre cells [38]. We suggest that a theoretical
effect of the mutation described in the present study could therefore be hyperexcitability of
postsynaptic granule cell membranes and/or receptor potentials being lost in the dendritic tree
instead of travelling to granule cell soma and via parallel fibres to Purkinje cells. We theorise
that the features observed in Purkinje cells [18] could be secondary to uncoordinated signal-
ling from granule cells. Interestingly, an in situ hybridisation study in mice demonstrated that
the KCNIPs that are expressed in the cerebellum, including KCNIP4, are expressed at a higher
level in the rostral lobe when compared to the caudal vermis [23]. Our immunohistochemical
findings showed the expression of KCNIP4 protein was lowest in the caudoventral vermis of
cases when compared to the rostral lobe, and this is also the region where the previous histo-
pathological findings showed the least expression of Purkinje cell differentiation marker pro-
teins (calbindin and ITPR-1) [18].
A potential limitation of the present study is the small number of affected dogs included in
the research; increasing the risk of a false positive finding. This is a result of the numerically
small size of the Buhund breed, and the limited availability of samples from affected dogs.
However, the availability of obligate carriers and other individuals from the extended pedigree
moderates this as a limitation. Genotyping large numbers of unaffected breed matched con-
trols, and multiple representatives of many different breeds, also minimised the effect of this
limitation. We were also unable to breed-match when performing RT-qPCR, western blot and
immunohistochemistry due to the lack of availability of relevant tissue, but this limitation was
minimised by the use of control samples from dogs of 3–6 diverse breeds. A potential limita-
tion of the WGS analysis pipeline used here is that it would not have detected structural vari-
ants or insertions and deletions larger than approximately 75 bp. Given that we identified a
compelling candidate causal variant in our current pipeline, we did not further investigate
larger structural or non-coding variants. However, both would require the use of gene candi-
dacy to generate a realistic number of variants for follow-up. Future refinement of structural
variant callers will enable their incorporation into pipelines for efficient analysis of WGS, with
necessary harmonisation amongst datasets.
In summary, by whole genome sequencing two Norwegian Buhund siblings, and filtering
against a bank of genomes of dogs of other breeds, we have identified a mutation associated
with cerebellar ataxia in this breed. The mutation is in a gene, KCNIP4, not previously impli-
cated in this disease in any species, and these findings could therefore inform research into
inherited ataxia of unknown aetiology in humans. This research has led to the development of
a DNA test for cerebellar ataxia in the Norwegian Buhund breed, allowing dog breeders to




Samples were collected from privately owned pet dogs from the general population, and
samples from the UK were in the form of buccal swabs or residual blood samples taken as
part of a veterinary procedure. This study was approved by the Animal Health Trust ethics
committee (AHT06-09). EDTA blood samples (3 ml) from 40 Norwegian Buhunds donated
to research were collected under the permission of animal ethical committee of County
Administrative Board of Southern Finland (ESAVI/343/04.10.07/2016) and all experiments
were performed in accordance with relevant guidelines and regulations and with owners’
written consent.
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Sample collection and DNA extraction
Samples from four Norwegian Buhunds diagnosed with cerebellar ataxia by veterinary neurol-
ogists at the Animal Health Trust Centre for Small Animal Studies, Newmarket, were included
in this research. Buccal swabs and post mortem tissue samples (stored in RNAlater) were col-
lected from two affected siblings diagnosed in 2008 (aged 12 weeks (0.2 years)). For the dogs
diagnosed in 1998 and 2002 (aged 16 and 20 weeks, respectively (0.3 and 0.4 years)) residual
formalin-fixed paraffin-embedded (FFPE) tissue samples, collected for histopathology at the
time of diagnosis, were used. Clinical descriptions and details of diagnosis have been described
previously [18].
For validation of potential causal variants, samples from three sets of unaffected Norwegian
Buhunds were utilised. The first set of DNA samples from 70 UK dogs were archived samples
which had previously been collected for an unrelated study between 2008 and 2011, with the
exception of one dog sampled in 2015 (“UK Set 1”). The dogs in this set were aged between 0.3
and 15.3 years (mean age 5.5 years) at sample collection, and none had been reported to have
ataxia by their owners. Two sets of DNA samples were collected in 2017 from Norwegian
Buhunds reported to have no signs of ataxia; one set from 36 dogs in the UK (“UK Set 2”) and
another from 40 dogs living in Finland (“Finnish Buhund Set”). Dogs in “UK Set 2” were aged
0.9 to 8.8 years (mean age 4.2 years), and in the Finnish Buhund Set were aged between 0.6
and 9.5 years (mean age 3.2 years).
DNA was extracted from buccal swabs using the QIAamp Midi Kit (Qiagen), or whole
blood using a standard chloroform protocol. DNA extraction from FFPE samples was carried
out using Recoverall total nucleic acid isolation kit (Ambion). In the Finnish cohort, genomic
DNA was extracted from the white blood cells using a semi-automated Chemagen extraction
robot (PerkinElmer Chemagen Technologie GmbH, Baeswieler, Germany) according to the
manufacturer’s instructions. DNA concentrations were measured using Qubit fluorometer
(Thermo Fisher Scientific, Waltham, Massachusetts, USA) and Nanodrop ND-1000 UV/Vis
Spectrophotometer (Nanodrop technologies, Wilmington, Delaware, USA) and samples were
stored at –20˚C.
RNA sequencing
Genome-wide RNA sequence analysis was carried out, using extant data generated as
described previously [18]. Visual inspection of gene transcripts was carried out using the Inte-
grative Genomics Viewer (IGV) [39].
Whole genome sequencing
Whole genome sequencing, including library preparation, of the two affected Norwegian
Buhund siblings was carried out by Edinburgh Genomics laboratories, University of Edin-
burgh, using Illumina 150 bp paired-end sequencing (approximately 40X coverage). The
library preparation method used was TruSeq DNA Nano (Illumina). Sequence reads were
aligned to the canine reference genome CanFam3.1 using the Burrows-Wheeler Aligner
(BWA-MEM), and SNP and in-del variants were called using the Genome Analysis Toolkit
(GATK) Haplotypecaller (v3.6) using GATK best practices [40, 41]. Consequence predictions
were designated for each variant using the Variant Effect Predictor (Ensembl), and variant
calls for genomes of 44 unrelated dogs of 29 other breeds, were used to filter variants [42]. The
initial 44 control genomes, and the additional 140 that later became available for assessment of
candidate variants, had been accrued over time for other research and as a resource.
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Genotyping
The initial genotyping for candidate variants identified as potentially causal was performed
using Sanger sequencing for eight SNPs, and fragment length analysis for a deletion, on an
ABI 3130XL Genetic Analyzer. Primer sequences are available in S6 Table. Hotstartaq plus
(Qiagen) was used for the initial PCR prior to sequencing, using the following cycling condi-
tions: 95˚C for 5 minutes, followed by 35 cycles of 30 seconds each at 95˚C and 57˚C, and
72˚C. Sanger sequencing used Bigdye terminator v3.1 ready reaction mix (Applied Biosys-
tems), using standard cycling conditions: 96˚C for 30 seconds, followed by 44 cycles of 4 sec-
onds at 92˚C, 4 seconds at 55˚C and 1 minute 30 seconds at 60˚C. Fragment length analysis
was carried out using a three primer system, utilising a forward primer designed with a “tail”
at the 5’ end and a fluorescently labelled (FAM) primer complementary to the “tail” on the for-
ward primer [43]. Hotstartaq plus (Qiagen) was used for PCR, and cycling conditions were as
follows: 94˚C for 4 minutes, followed by 30 cycles of 30 seconds each at 94˚C and 57˚C, and 1
minute at 72˚C. This was followed by eight cycles of 30 seconds each at 94˚C and 50˚C, and 1
minute at 72˚C. The cycling was concluded with a 30 minute extension step at 72˚C.
Further genotyping for the KCNIP4 variant utilised an allelic discrimination method, using
an ABI StepOne real-time thermal cycler. The assay primer and probe sequences are in S7
Table. The Kapa probe fast master mix (Kapa Biosystems) was used for genotyping all dogs,
except those for which samples were collected as FFPE tissue. To optimise genotyping of the
latter by limiting the levels of PCR inhibitors, DNA isolated from FFPE samples was further
purified by ethanol precipitation before genotyping. FFPE derived DNA samples were geno-
typed using the Taqpath Proamp master mix (Applied Biosystems). For allelic discrimination
assays using KAPA Probe Fast and DNA from buccal swabs or blood samples, a fast ramping
speed was used and the following cycling conditions were used: 30 seconds Pre-PCR read at
25˚C, 95˚C holding stage for 3 minutes, 40 cycles of 95˚C for 3 seconds and 60˚C for 10 sec-
onds, followed by a 30 second post-PCR read step at 25˚C. Allelic discrimination assays using
Taqpath Proamp used the standard ramping speed and the following cycling conditions: 60˚C
for 30 seconds pre-PCR read, 5 minute 95˚C holding stage, 40 cycles of 15 seconds at 95˚C and
1 minute at 60˚C, and 60˚C for 30 seconds post-PCR read step.
RT-qPCR
RNA was extracted from cerebellum samples collected post-mortem from the two affected
Norwegian Buhund siblings and five other dogs unaffected by ataxia of different breeds (Lab-
rador Retriever cross-breed, Siberian Husky cross-breed, Beagle, Golden Retriever, and a
Great Dane) Elimination of genomic DNA and reverse transcription was carried out using the
Quantitect cDNA synthesis kit (Qiagen). Assay primers and probe were designed for qPCR
with the fluorescently labelled probe overlapping the boundaries of exons present in all alter-
native KCNIP4 transcripts (Forward: GCCCAGAGCAAATTTACCAAG, probe: AAGAATG
AGTGTCCCAGCGGTGT, reverse: CGGAAAGAACTGCGAGTAAATC). The qPCR was
carried out using Luna Universal qPCR Master Mix (NEB) and an ABI StepOnePlus real-time
PCR system, and comparative CT analysis used for relative quantification compared to an
assay for the ubiquitously expressed TATA box binding protein (TBP) gene. Reaction effi-
ciency was calculated by performing a seven point, doubling dilution, standard curve. The
reaction efficiencies of both the KCNIP4 and TBP assays were 99.2%.
PCR and sanger sequencing of transcripts
PCR primers were designed to be specific to each transcript, with a unique forward primer
designed to overlap the boundary of the first and second exon and a reverse primer in the final
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exon which all transcripts share: GCATGGAGCGCATTATGTTT (S8 Table). Hotstartaq plus
(Qiagen) was used for PCR of the cDNA produced by reverse transcription for the two
Buhunds and five control dogs (see above), and cycling conditions were as follows: 95˚C for 5
minutes, followed by 35 cycles of 30 seconds each at 95˚C and 57˚C, and 72˚C. This was fol-
lowed by final step at 72˚C for 5 minutes. Agarose gel electrophoresis (1.5% agarose, 100v for
one hour) was carried out using 3μL of each product and images were taken. Sanger sequenc-
ing was carried out on the products for the two Norwegian Buhunds and Golden Retriever, as
described above.
Western blot
Cerebellum tissue from the two cerebellar ataxia-affected Norwegian Buhund siblings and six
control dogs were homogenised in radioimmunoprecipitation assay (RIPA) buffer (Cell Sig-
nalling Technology). The six control dogs included three dogs affected by cerebellar ataxia, but
clear of the KCNIP4 mutation and of breeds for which the causal mutation is known (one of
each of Parson Russel Terrier, Beagle, and Hungarian Vizsla). The Parson Russel Terrier was
diagnosed with late-onset spinocerebellar ataxia, and both the Beagle and Hungarian Vizsla
with CCD, and all three were homozygous for the applicable causal variant for their form of
ataxia [5, 15, 16]. The remaining three control dogs were unaffected by ataxia and clear of the
mutation: one of each of Golder Retriever, Siberian Husky cross breed, Labrador Retriever
cross-breed. Total protein lysate (15 μl, 180–255 μg) was diluted in Laemmli sample buffer
(BIO-RAD) and separated by SDS-polyacrylamide gel electrophoresis using a 4–20% Mini-
PROTEAN TGX Stain-Free precast gel (BIO-RAD). Wet transfer was used to transfer proteins
onto a nitrocellulose membrane (0.45 μm). Immunoblotting was carried out using a rabbit
monoclonal primary antibody targeting KCNIP4 (abcam, ab203831). The immunogen for the
primary antibody used was a recombinant protein covering all of KCNIP4 (KCNIP4-1a,
ENST00000382152.7), from the first amino acid to the C-terminus. Protein band detection uti-
lised the WesternBreeze anti-rabbit chromogenic kit (Invitrogen) which uses a goat anti-rabbit
antibody and conjugated alkaline phosphatase for detection. Ponceau S stain was used as a
total protein loading control.
Immunohistochemistry
Tissue expression of KCNIP4 was evaluated immunohistochemically in transverse and sagittal
sections of cerebella of one affected Buhund sibling and three neurologically healthy control
dogs (Labrador Retriever, Australian Shepherd, Jack Russell Terrier). The staining employed
the same antibody as used for western blot (as described above), polymer technology and a dia-
minobenzidine tetrahydrochloride detection kit. Slides were counterstained with haematoxy-
lin and routinely coverslipped using xylene-based mounting medium.
In silico protein analysis
In silico protein analysis was carried out using a 3D model (PDB ID 3DD4) obtained from the
PDB-REDO Databank (pdb-redo.eu). The model had been refined and rebuilt from the origi-
nal PDB model which had been determined through X-ray diffraction [35]. The model was
visualised using UCSF Chimera software [44], and the two missing loops were modelled using
Modeller [45]. Heteroatoms were removed from the PDB file, and a model of the protein con-
taining the variant was created using Chimera’s Rotamers tool, choosing the arginine rotamer
with the highest probability in the Dunbrack library [46]. Clashes and contacts were predicted
using Chimera’s “Find Clashes/Contacts” tool which uses van der Waals radii to find inter-
atomic clashes and contacts. The software’s default clash and contact criteria were used.
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Clashes: van der Waals overlap > = 0.6 angstroms, subtracting 0.4 for H-bonding pairs. Con-
tacts: van der Waals overlap > = -0.4 angstroms.
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those demonstrated to be expressed in canine cerebellum.
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S8 Table. Transcript-specific primers for KCNIP4.
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ing highlighted.
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S2 Fig. UCSC Multiz Alignments of 20 species of mammal (17 primates) Human GRCh38/
hg38 Assembly 4: 20,734,628–20,734,726. The amino acid at the location of the mutation is
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